Skip to main content
. 2017 Aug 2;8(39):66087–66097. doi: 10.18632/oncotarget.19798

Figure 1. RAS expressions in controls and AML patients including newly diagnosed AML, AML at complete remission time, and relapsed AML.

Figure 1

(A) KRAS expression. (B) NRAS expression.